Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
A tri-omics and machine learning framework identifies prognostic biomarkers and metabolic signatures in sepsis
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 29 January 2026

A tri-omics and machine learning framework identifies prognostic biomarkers and metabolic signatures in sepsis

  • Xiang Li1,
  • Gege Ke1,
  • Yingchun Hu1 &
  • …
  • Muhu Chen1 

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biomarkers
  • Computational biology and bioinformatics

Abstract

Sepsis is a complex systemic inflammatory syndrome that currently lacks stable and specific biomarkers. Multi-omics integration combined with machine learning and single-cell analysis offers new approaches for elucidating molecular mechanisms and nominating candidate regulators for further validation. Establish an integrated analytical framework combining transcriptomics, proteomics, metabolomics, and single-cell transcriptomics to identify sepsis-associated candidates and generate testable hypotheses for downstream mechanistic and translational studies. A multi-omics integrative framework was established by combining transcriptomic, proteomic, and metabolomic data. Weighted gene co-expression network analysis (WGCNA) was first applied to identify modules significantly associated with sepsis, and key candidate genes were further refined using LASSO regression and SVM-RFE algorithms. Compare differentially expressed transcripts and proteins through quadrant analysis. Further leverage open-access proteome-phenome resources to assess the association between priority target proteins and sepsis-related phenotypes/disease risk. Metabolomic profiling was conducted to identify metabolites significantly correlated with the core genes and their enriched pathways. A joint gene–metabolite classification model was then constructed using logistic regression, support vector machines, and random forests, with predictive performance evaluated using ROC curve analysis. LASSO regression was used to visualize coefficient shrinkage and effect direction, while random forest–based feature importance quantified the relative contribution of each variable. Finally, leveraging the ITCM database, an in silico screening was performed to identify natural compounds with potential regulatory effects on TPR and ERN1 expression. TPR and ERN1 were prioritized as key candidate biomarkers associated with sepsis. External validation in GEO cohorts and analyses of protein–disease risk association databases further supported their reproducible disease association in external datasets, motivating further validation of their prognostic/diagnostic potential. Non-targeted metabolomics screening identified 136 differentially expressed metabolites associated with them, primarily enriched in glycerophospholipid metabolism and fatty acid-related pathways. Metabolite-gene correlation integration linked these metabolic alterations to TPR/ERN1, suggesting their potential involvement in immune-metabolic pathway remodeling associated with sepsis heterogeneity. Single-cell transcriptomics provided cellular origin-level support, showing enrichment of TPR and ERN1 expression in immune subpopulations, including monocyte-macrophages and NK cells. A joint gene-metabolite model constructed using a fixed feature set (2 genes + 5 metabolites) demonstrated strong discriminatory potential in an internally derived cohort, though external validation in independent, multi-omics matched cohorts remains urgently needed. Finally, exploratory computational screening based on the ITCM database identified several potential active monomers in traditional Chinese medicine that may influence TPR or ERN1 expression, providing hypothesis-generating clues for subsequent mechanistic studies and drug translation. By integrating multi-omics data, TPR and ERN1 were identified as sepsis-associated candidate biomarkers and linked to immune-metabolic alterations associated with immune cells. The combined gene-metabolite signature panel and exploratory compound screening provide a hypothesis-generating framework for downstream experimental validation and clinical study design.

Similar content being viewed by others

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Article Open access 27 April 2024

Utilizing integrated bioinformatics and machine learning approaches to elucidate biomarkers linking sepsis to purine metabolism-associated genes

Article Open access 02 January 2025

Immunogenic cell death biomarkers for sepsis diagnosis and mechanism via integrated bioinformatics

Article Open access 27 May 2025

Data availability

Histological data from 21 sepsis patients and 10 healthy volunteers are available through the Chinese National GeneBank DataBase (CNGBdb) at db.cngb.org/ under accession number CNP0002611 (permanent link). Public transcriptomic datasets used in this study are available in the Gene Expression Omnibus (GEO) repository (https://www.ncbi.nlm.nih.gov/geo/) under accession numbers GSE65682, GSE163151, GSE232753, GSE95233, GSE69063, GSE243217, GSE236713, GSE185263, GSE154918, GSE134347, and GSE100159. Additional datasets generated and/or analyzed during the current study are included in the Supplementary Information files. The code and scripts are available upon request from the corresponding author.

References

  1. Angus, DC, Bindman, AB, (2022). Achieving Diagnostic Excellence for Sepsis. JAMA-J AM MED ASSOC, 327 JAMA-J AM MED ASSOC. https://doi.org/10.1001/jama.2021.23916

  2. Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., Fleischmann-Struzek, C., Machado, F. R., Reinhart, K. K., Rowan, K., Seymour, C. W., Watson, R. S., West, T. E., Marinho, F., Hay, S. I., Lozano, R., … Naghavi, M. (2020). Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet (London, England), 395(10219), 200–211. https://doi.org/10.1016/S0140-6736(19)32989-7

  3. Jacob, S. T., Banura, P., Baeten, J. M., Moore, C. C., Meya, D., Nakiyingi, L., Burke, R., Horton, C. L., Iga, B., Wald, A., Reynolds, S. J., Mayanja-Kizza, H., Scheld, W. M., & Promoting Resource-Limited Interventions for Sepsis Management in Uganda Study Group. The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study*. Crit. Care Med. 40(7), 2050–2058. https://doi.org/10.1097/CCM.0b013e31824e65d7 (2012).

    Google Scholar 

  4. Gupta, R. G., Hartigan, S. M., Kashiouris, M. G., Sessler, C. N. & Bearman, G. M. Early goal-directed resuscitation of patients with septic shock: Current evidence and future directions. Critical care (London, England) 19(1), 286 (2015).

    Google Scholar 

  5. Song, L. et al. Post-translational modifications in sepsis-induced organ dysfunction: Mechanisms and implications. Front. Immunol. 15, 1461051. https://doi.org/10.3389/fimmu.2024.1461051 (2024).

    Google Scholar 

  6. Schuurman, A. R., Chouchane, O., Butler, J. M., Peters-Sengers, H., Joosten, S., Brands, X., Haak, B. W., Otto, N. A., Uhel, F., Klarenbeek, A., van Linge, C. C., van Kampen, A., Pras-Raves, M., van Weeghel, M., van Eijk, M., Ferraz, M. J., Faber, D. R., de Vos, A., Scicluna, B. P., Vaz, F. M., … van der Poll, T. (2024). The shifting lipidomic landscape of blood monocytes and neutrophils during pneumonia. JCI insight, 9(4), e164400. https://doi.org/10.1172/jci.insight.164400

  7. Birner, C. et al. Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious disease reports 16(5), 806–819. https://doi.org/10.3390/idr16050062 (2024).

    Google Scholar 

  8. Liu, J., Zhou, G., Wang, X. & Liu, D. Metabolic reprogramming consequences of sepsis: Adaptations and contradictions. Cellular and molecular life sciences : CMLS 79(8), 456. https://doi.org/10.1007/s00018-022-04490-0 (2022).

    Google Scholar 

  9. Assis, P. A., Allen, R. M., Schaller, M. A., Kunkel, S. L., & Bermick, J. R. (2024). Metabolic reprogramming and dysregulated IL-17 production impairs CD4 T cell function post sepsis. iScience, 27(7), 110114. https://doi.org/10.1016/j.isci.2024.110114

  10. Wang, Y. et al. Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs. Front. Immunol. 12, 634127. https://doi.org/10.3389/fimmu.2021.634127 (2021).

    Google Scholar 

  11. Hartman, E. et al. Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis. Nat. Commun. 14(1), 5359. https://doi.org/10.1038/s41467-023-41146-4 (2023).

    Google Scholar 

  12. Bomrah, S. et al. A scoping review of machine learning for sepsis prediction- feature engineering strategies and model performance: A step towards explainability. Critical care (London, England) 28(1), 180. https://doi.org/10.1186/s13054-024-04948-6 (2024).

    Google Scholar 

  13. Lee, Y. S., Han, S., Lee, Y. E., Cho, J., Choi, Y. K., Yoon, S. Y., Oh, D. K., Lee, S. Y., Park, M. H., Lim, C. M., Moon, J. Y., & Korean Sepsis Alliance (KSA) Investigators (2024). Development and validation of an interpretable model for predicting sepsis mortality across care settings. Scientific reports, 14(1), 13637. https://doi.org/10.1038/s41598-024-64463-0

  14. Antcliffe, D. B., Burnham, K. L., Al-Beidh, F., Santhakumaran, S., Brett, S. J., Hinds, C. J., Ashby, D., Knight, J. C., & Gordon, A. C. (2019). Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial. American journal of respiratory and critical care medicine, 199(8), 980–986. https://doi.org/10.1164/rccm.201807-1419OC

  15. Tsou, C. C. et al. DIA-Umpire: Comprehensive computational framework for data-independent acquisition proteomics. Nat. Methods 12(3), 258–264. https://doi.org/10.1038/nmeth.3255 (2015).

    Google Scholar 

  16. Wishart, DS., Feunang, YD., Marcu, A., Guo, AC., Liang, K., Vázquez-Fresno, R., Sajed, T., Johnson, D., Li, C., Karu, N., Sayeeda, Z., Lo, E., Assempour, N., Berjanskii, M., Singhal, S., Arndt, D., Liang, Y., Badran, H., Grant, J., Serra-Cayuela, A., Liu, Y., Mandal, R., Neveu, V., Pon, A., Knox, C., Wilson, M., Manach, C., Scalbert, A, (2018). HMDB 4.0: The human metabolome database for 2018. NUCLEIC ACIDS RES, 46 (D1), D608-D617.

  17. Li, S. et al. Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis. Sci Rep 14(1), 23130. https://doi.org/10.1038/s41598-024-74040-0 (2024).

    Google Scholar 

  18. Li, Y., Wang, C. & Chen, M. Metabolomics-based study of potential biomarkers of sepsis. Sci Rep 13(1), 585. https://doi.org/10.1038/s41598-022-24878-z (2023).

    Google Scholar 

  19. Li, S. et al. Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis. Sci. Rep. 14(1), 23130. https://doi.org/10.1038/s41598-024-74040-0 (2024).

    Google Scholar 

  20. Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9, 559. https://doi.org/10.1186/1471-2105-9-559 (2008).

    Google Scholar 

  21. Choi, M. et al. MSstats: An R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics 30(17), 2524–2526. https://doi.org/10.1093/bioinformatics/btu305 (2014).

    Google Scholar 

  22. Xue, Z., Zhu, T., Zhang, F., Zhang, C., Xiang, N., Qian, L., Yi, X., Sun, Y., Liu, W., Cai, X., Wang, L., Dai, X., Yue, L., Li, L., Pham, TV., Piersma, SR., Xiao, Q., Luo, M., Lu, C., Zhu, J., Zhao, Y., Wang, G., Xiao, J., Liu, T., Liu, Z., He, Y., Wu, Q., Gong, T., Zhu, J., Zheng, Z., Ye, J., Li, Y., Jimenez, CR., A, J., Guo, T, (2023). DPHL v.2: An updated and comprehensive DIA pan-human assay library for quantifying more than 14,000 proteins. Patterns (N Y), 4 (7), 100792. https://doi.org/10.1016/j.patter.2023.100792

  23. Mehnert, M. et al. Multi-layered proteomic analyses decode compositional and functional effects of cancer mutations on kinase complexes. Nat Commun 11(1), 3563. https://doi.org/10.1038/s41467-020-17387-y (2020).

    Google Scholar 

  24. Mu, H. et al. OmicShare tools: A zero-code interactive online platform for biological data analysis and visualization. Imeta 3(5), e228. https://doi.org/10.1002/imt2.228 (2024).

    Google Scholar 

  25. Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J. Stat. Softw. 33(1), 1–22 (2010).

    Google Scholar 

  26. Wang, Q. & Liu, X. Screening of feature genes in distinguishing different types of breast cancer using support vector machine. Onco. Targets. Ther. 8, 2311–2317 (2015).

    Google Scholar 

  27. Xu, J. H., Chang, W. H., Fu, H. W., Yuan, T. & Chen, P. The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus. Mol. Med. Rep. 17(5), 6472–6482. https://doi.org/10.3892/mmr.2018.8694 (2018).

    Google Scholar 

  28. Deng, Y. T. et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell 188(1), 253-271.e7. https://doi.org/10.1016/j.cell.2024.10.045 (2024).

    Google Scholar 

  29. Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16(5), 284–287. https://doi.org/10.1089/omi.2011.0118 (2012).

    Google Scholar 

  30. Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27–30. https://doi.org/10.1093/nar/28.1.27 (2000).

    Google Scholar 

  31. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44(D1), D457–D462. https://doi.org/10.1093/nar/gkv1070 (2016).

    Google Scholar 

  32. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. P NATL ACAD SCI USA 102(43), 15545–15550. https://doi.org/10.1073/pnas.0506580102 (2005).

    Google Scholar 

  33. Zheng, X. et al. Predictive modeling of mortality risk in septic shock patients based on supervised machine learning algorithm. Chinese Emergency Medicine for Critical Illness 36(4), 345–352. https://doi.org/10.3760/cma.j.cn121430-20230930-00832 (2024).

    Google Scholar 

  34. Tian, S., Zhang, J., Yuan, S., Wang, Q., Lv, C., Wang, J., Fang, J., Fu, L., Yang, J., Zu, X., Zhao, J., & Zhang, W. (2023). Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM. Briefings in bioinformatics, 24(2), bbad027. https://doi.org/10.1093/bib/bbad027

  35. ZHANG Cuicui, QIN Tingting, MENG Zhaoting, LI Kai. Research advances in abnormal lipid metabolism of lung cancer. China Oncology, 2021, 31(1): 76–80.

  36. Dou, H. et al. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency. Circulation 144(24), 1940–1954. https://doi.org/10.1161/CIRCULATIONAHA.121.056414 (2021).

    Google Scholar 

  37. Wang, B, Wu, L, Chen, J, Dong, L, Chen, C, Wen, Z, Hu, J, Fleming, I, Wang, DW, (2021). Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets. SIGNAL TRANSDUCT TAR, 6 SIGNAL TRANSDUCT TAR. https://doi.org/10.1038/s41392-020-00443-w

  38. O'Flaherty, J. T., Lees, C. J., Miller, C. H., McCall, C. E., Lewis, J. C., Love, S. H., & Wykle, R. L. (1981). Selective desensitization of neutrophils: Further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues. Journal of immunology (Baltimore, Md. : 1950), 127(2), 731–737.

  39. Krull, S., Thyberg, J., Björkroth, B., Rackwitz, H. R. & Cordes, V. C. Nucleoporins as components of the nuclear pore complex core structure and TPR as the architectural element of the nuclear basket. Mol. Biol. Cell 15(9), 4261–4277. https://doi.org/10.1091/mbc.e04-03-0165 (2004).

    Google Scholar 

  40. Krull, S. et al. Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion. EMBO J. 29(10), 1659–1673. https://doi.org/10.1038/emboj.2010.54 (2010).

    Google Scholar 

  41. Raices, M. & D’Angelo, M. A. Nuclear pore complex composition: A new regulator of tissue-specific and developmental functions. Nat. Rev. Mol. Cell Biol. 13(11), 687–699. https://doi.org/10.1038/nrm3461 (2012).

    Google Scholar 

  42. Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell Biol. 21(8), 421–438. https://doi.org/10.1038/s41580-020-0250-z (2020).

    Google Scholar 

  43. Sheppard, T. Unfolded protein response: Letting go of stress NAT CHEM BIOL 10(11), 877–877. https://doi.org/10.1038/nchembio.1676 (2014).

    Google Scholar 

  44. Hetz, C., Martinon, F., Rodriguez, D. & Glimcher, L. H. The unfolded protein response: Integrating stress signals through the stress sensor IRE1α. Physiol. Rev. 91(4), 1219–1243. https://doi.org/10.1152/physrev.00001.2011 (2011).

    Google Scholar 

  45. Eckerle, M. et al. Metabolomics as a Driver in Advancing Precision Medicine in Sepsis. Pharmacotherapy 37(9), 1023–1032. https://doi.org/10.1002/phar.1974 (2017).

    Google Scholar 

  46. Xiao, X., Ye, M., Xu, Y. & Jiang, C. Zhonghua wei zhong bing ji jiu yi xue 32(3), 382–384. https://doi.org/10.3760/cma.j.cn121430-20200226-00238 (2020).

    Google Scholar 

  47. Li, P., Li, X., Wu, Y., Li, M., & Wang, X. (2017). A novel AMPK activator hernandezine inhibits LPS-induced TNFα production. Oncotarget, 8(40), 67218–67226. https://doi.org/10.18632/oncotarget.18365

  48. Yu, T. et al. Hernandezine alleviates inflammatory bowel disease by enhancing gut barrier integrity via the AMPK/NRF2 pathway and regulating immune-metabolic balance. Int Immunopharmacol 163, 115230. https://doi.org/10.1016/j.intimp.2025.115230 (2025).

    Google Scholar 

  49. Córdova-Isaza, A., Jiménez-Mármol, S., Guerra, Y., Salas-Sarduy, E, (2023). Enzyme Inhibitors from Gorgonians and Soft Corals. Mar Drugs, 21 (2),

  50. Yaxuan, S. I. & Yong, Y. A. N. G. Metabolic Regulation and Intervention Strategies of Tumor Infiltrating T Cells. Progress in Pharmaceutical Sciences 47(1), 56–65. https://doi.org/10.20053/j.issn1001-5094.2023.01.006 (2023).

    Google Scholar 

  51. Liang, J., Li, T., Zhao, J., Wang, C. & Sun, H. Current understanding of the human microbiome in glioma. Front Oncol 12, 781741. https://doi.org/10.3389/fonc.2022.781741 (2022).

    Google Scholar 

  52. Li, F., Zhao, Y., Wei, L., Li, S. & Liu, J. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Cancer Biol. Ther. 19(8), 695–705. https://doi.org/10.1080/15384047.2018.1450116 (2018).

    Google Scholar 

  53. Rocha, S. M. et al. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation. J. Neuroinflammation 13(1), 137. https://doi.org/10.1186/s12974-016-0600-0 (2016).

    Google Scholar 

  54. Yuan, X., Zhu, J., Kang, Q., He, X., & Guo, D. (2019). Protective Effect of Hesperidin Against Sepsis-Induced Lung Injury by Inducing the Heat-Stable Protein 70 (Hsp70)/Toll-Like Receptor 4 (TLR4)/ Myeloid Differentiation Primary Response 88 (MyD88) Pathway. Medical science monitor : International medical journal of experimental and clinical research, 25, 107–114. https://doi.org/10.12659/MSM.912490

  55. Ny, V., Houška, M., Pavela, R. & Tříska, J. Potential benefits of incorporating Astragalus membranaceus into the diet of people undergoing disease treatment: An overview. Journal of Functional Foods 77, 104339 (2021).

    Google Scholar 

  56. Lee, J. H., Koo, T. H., Hwang, B. Y. & Lee, J. J. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J. Biol. Chem. 277(21), 18411–18420. https://doi.org/10.1074/jbc.M201368200 (2002).

    Google Scholar 

  57. Zhou Y, Su X, Wang C, Alarfaj AA, Hajinur Hirad A. Toosendanin Attenuates Mycoplasma pneumonia Induced Pneumonia (MPP) in Mice via Inhibiting NF-κB-Mediated Inflammatory Response: In vivo and silico Studies. Dose-Response. 2025;23(3). https://doi.org/10.1177/15593258251367619

  58. Mo, C. et al. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid. Redox Signal. 20(4), 574–588. https://doi.org/10.1089/ars.2012.5116 (2014).

    Google Scholar 

  59. Li, C., Liu, K., Liu, S., Aerqin, Q. & Wu, X. Role of Ginkgolides in the Inflammatory Immune Response of Neurological Diseases: A Review of Current Literatures. Front Syst Neurosci. 31(14), 45. https://doi.org/10.3389/fnsys.2020.00045.PMID:32848639;PMCID:PMC7411855 (2020).

    Google Scholar 

  60. Zhang, J. et al. Cantharidin: A double-edged sword in medicine and toxicology. Front. Pharmacol. 16, 1644186. https://doi.org/10.3389/fphar.2025.1644186 (2025).

    Google Scholar 

Download references

Acknowledgements

We thank the open-access proteome-phenome resource database established by Huashan Hospital of Fudan University (https://proteome-phenome-atlas.com/) and BGI for guidance on single-cell sequencing.

Funding

Financial support for this research was provided by the Science and Technology Bureau of Luzhou City (Grant No. 2024LZXNYDJ038), the Sichuan Provincial Medical Research Project (Grant No. S20250001), and the Sichuan Science and Technology Department Project (Grant No. 2026YFHZ0136).

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China

    Xiang Li, Gege Ke, Yingchun Hu & Muhu Chen

Authors
  1. Xiang Li
    View author publications

    Search author on:PubMed Google Scholar

  2. Gege Ke
    View author publications

    Search author on:PubMed Google Scholar

  3. Yingchun Hu
    View author publications

    Search author on:PubMed Google Scholar

  4. Muhu Chen
    View author publications

    Search author on:PubMed Google Scholar

Contributions

X.L. performed the data analysis, prepared the figures, and drafted the manuscript. G.K. was responsible for sample collection and data curation. Y.H. contributed to the initial study conception and design. M.C. reviewed and edited the manuscript and provided overall supervision. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yingchun Hu or Muhu Chen.

Ethics declarations

Competing interests

The authors confirm that they have no conflicts of interest.

Ethical approval

This investigation was performed in full alignment with the Declaration of Helsinki. The ethics committee of the Affiliated Hospital of Southwest Medical University approved the study protocol (Ethical Approval No. ky2018029). The trial is registered under ChiCTR1900021261.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Xiang Li and Gege Ke are co-first authors.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Ke, G., Hu, Y. et al. A tri-omics and machine learning framework identifies prognostic biomarkers and metabolic signatures in sepsis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-37342-z

Download citation

  • Received: 07 November 2025

  • Accepted: 21 January 2026

  • Published: 29 January 2026

  • DOI: https://doi.org/10.1038/s41598-026-37342-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Sepsis
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Cohort studies
  • Joint diagnostic models
Download PDF

Associated content

Collection

Sepsis: Treatment, intervention, mortality

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research